PRM — Proteome Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- £4.46m
- £19.59m
- £4.89m
Annual cashflow statement for Proteome Sciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.245 | 0.072 | 1.32 | -2.44 | -3.41 |
| Depreciation | |||||
| Non-Cash Items | 0.312 | 0.882 | 0.999 | 1.41 | 1.17 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.861 | -0.374 | -0.29 | 0.429 | 0.574 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.58 | 0.793 | 2.14 | -0.481 | -0.826 |
| Capital Expenditures | -0.013 | -0.204 | -0.319 | -0.237 | -0.224 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0 | -0.187 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.013 | -0.204 | -0.319 | -0.424 | -0.224 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.146 | -0.4 | -0.209 | -1.06 | 0.151 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.41 | 0.177 | 1.61 | -1.97 | -0.899 |